Evidence map›Paper›PMID 36967529›Full record

ArticleGut microbes

Glycoursodeoxycholic acid regulates bile acids level and alters gut microbiota and glycolipid metabolism to attenuate diabetes.

Bingting Chen, Yu Bai, Fenglian Tong, Junlin Yan, Rui Zhang, Yewei Zhong, Huiwen Tan, Xiaoli Ma

Open access · goldAbstract read
In one paragraph

Article in Gut microbes. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 87 papers.

0numbers the graph read from it
0cells of the map it votes in
87citing papers in PubMed
16.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

87 citing papers in PubMed, 108 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article

27 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Bingting ChenCollege of Pharmacy, Xinjiang Medical University, Urumqi, China.
Yu BaiThe Fourth Affiliated Hospital of Xinjiang Medical University, Urumqi, China.
Fenglian TongCollege of Pharmacy, Xinjiang Medical University, Urumqi, China.
Junlin YanCollege of Pharmacy, Xinjiang Medical University, Urumqi, China.
Rui ZhangCollege of Pharmacy, Xinjiang Medical University, Urumqi, China.
Yewei ZhongCollege of Pharmacy, Xinjiang Medical University, Urumqi, China.
Huiwen TanCollege of Pharmacy, Xinjiang Medical University, Urumqi, China.
Xiaoli MaCollege of Pharmacy, Xinjiang Medical University, Urumqi, China.ORCID 0000-0003-3127-0364
Xinjiang Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Accumulating evidence suggests that the bile acid regulates type 2 diabetes mellitus (T2DM) through gut microbiota-host interactions. However, the mechanisms underlying such interactions have been unclear. Here, we found that glycoursodeoxycholic acid (GUDCA) positively regulates gut microbiota by altering bile acid metabolism. GUDCA in mice resulted in higher taurolithocholic acid (TLCA) level and

Indexed as

Diabetes Mellitus, Type 2Gastrointestinal MicrobiomeAnimalsBile Acids and SaltsGlycolipidsMiceReceptors, G-Protein-CoupledUrsodeoxycholic AcidBile Acids and SaltsGlycolipidsglycoursodeoxycholic acidGpbar1 protein, mouseReceptors, G-Protein-CoupledUrsodeoxycholic Acidbile acidsglycoursodeoxycholic acidgut microbiotaType 2 diabetes

Identifiers

PMID36967529
PMCPMC10054359
OpenAlexW4360985160

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.